Predictive Human Toxicity and ADME/Tox Studies
Evaluation of ADMET Drug Properties in Drug Discovery and Development
January 27th - 28th, 2015
London, United Kingdom
Click here for training course agenda and details.
10thAnnual International Conference on Predictive Human Toxicity and ADME/Tox Studies
January 29th - 30st, 2015
London, United Kingdom
Mondial Research Group will bring together scientific experts from the Biotech and Pharmaceutical Industry to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.
In this 10th year we will explore the latest and novel technologies being used in the field of Predictive Toxicology and ADME/Tox. The inclusion of the 3r's principles will also be explored in great depth through the co-location of our Reduced Animal Testing Conference. Below are some of the speakers that will be presenting at the conference.
Mark Seymour (Xceleron) – Human Microdosing and Beyond: Enhancing Early Clinical Development using AMS
Bart van der Burg (EC/JRC) - Chemscreen: An In Vitro Test Battery to Detect Reproductive Toxicants
Amin Rostami (University of Manchester) - CSS program (Cardiac Safety Simulator)
Nick Thomas (GE Life Sciences)- Multi-Electrode Arrays Comprehensive Assessment of Drug Cardiac Liabilities
Brett Howell (The Hamner Institute) - Applications of a Mechanistic Model of Drug-Induced Liver Injury (DILIsym®) in Predictive Toxicology
Peter O’Brien (University College Dublin)- HCA and Predictive Toxicity testing
Jayne Wright (Syngenta) – Biomarkers of Target Organ Specific Changes and Exposure Based Thresholds
Vincent Paget (CEA France) - Carboxylated Nanodiamonds are Neither Cytotoxic Nor Genotoxic on Human Cell Lines and are Potential Negative Control for Nanotoxicology Studies
Andras Dinnyes (Utrecht University) - ESCs and iPSCs in Drug Discovery and Toxicity Testing
Richard Thompson (AstraZeneca) - Risk Assessment and Mitigation Strategies for Reactive Metabolites in Drug Discovery
Anna Fischer-Berenbein (Bayer) - New In Vitro Method to Predict Immunosuppresive Effects of Compounds with Blood Cells of different Species Including Humans
There is an open call for papers. The Deadline is October 31, 2014. You may submit your abstract by Clicking Here.
Your topics should fall within the scope of Predictive Toxicology, ADME/TOX, or 3r's.
There will be an extensive short course on "Evaluation of ADMET Drug Properties in Drug Discovery and Development" the two days prior to the conference.
If you would like to receive information on Sponsoring or Exhibiting at this event please contact us using the email below.
Sponsorship / Exhibition
Dr. James Paxton.
Training / Conference & Media Queries
Cristina C. Lungu